Until recently, percutaneous balloon aortic valvuloplasty (PBAV) had limited indications as a bridge to surgical aortic valve replacement in elderly patients with depressed left ventricular function. Since the advent of transcatheter aortic valve implantation (TAVI), most high-surgical risk patients are currently referred for TAVI, allowing for a new role for PBAV in three subsets of patients who cannot perform TAVI as first-line treatment: presence of hemodynamic instability-PBAV may improve the clinical status and allow to perform TAVI; presence of a low-flow low-gradient aortic stenosis-PBAV may reveal who benefits from a stable decrease in aortic gradient; and need for major noncardiac surgery-PBAV may reduce the operative risk and allow subsequent definition of the indication to TAVI. © 2014 Future Medicine Ltd.
How transcatheter aortic valve implantation can revive balloon aortic valvuloplasty
Petronio A. S.;Giannini C.;De Caro F.;De Carlo M.
2014-01-01
Abstract
Until recently, percutaneous balloon aortic valvuloplasty (PBAV) had limited indications as a bridge to surgical aortic valve replacement in elderly patients with depressed left ventricular function. Since the advent of transcatheter aortic valve implantation (TAVI), most high-surgical risk patients are currently referred for TAVI, allowing for a new role for PBAV in three subsets of patients who cannot perform TAVI as first-line treatment: presence of hemodynamic instability-PBAV may improve the clinical status and allow to perform TAVI; presence of a low-flow low-gradient aortic stenosis-PBAV may reveal who benefits from a stable decrease in aortic gradient; and need for major noncardiac surgery-PBAV may reduce the operative risk and allow subsequent definition of the indication to TAVI. © 2014 Future Medicine Ltd.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
